1-(tert-Butoxycarbonyl)-4-(4-fluorophenyl)piperidine-4-carboxylic acid, 95.0%, 250mg

(S)-1-(3-Fluoro-2-nitrophenyl)pyrrolidin-3-amine hydrochloride, 95.0%, 1g

1-(2-Bromophenyl)-1H-pyrrole-2,5-dione, 95.0%, 1g

3,5-Diiodo-2-methylpyridin-4-amine, 95+%, 1g

Methyl 3-Hydroxythiophene-2-carboxylate, 97.0%, 500g

2-([1,1'-Biphenyl]-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane>98.0%(GC)(T)1g

3-Fluorobenzene-1,2-diamine, 97.0%, 25g

Flat flange reaction vial, cylindrical, graduated, with tempering jacket GL connecting piece, DN 100, 2000 ml, 130 mm, 1 Piece

tert-butyl 3-(cyclopropylamino)propanoate, 95.0%, 10g

6-Fluoroquinolin-5-amine, 95+%, 100mg

8-Bromo-5-chloroimidazo[1,5-a]pyridine, 97%, 250mg

N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-4-piperidone>98.0%(HPLC)1g

4-Iodo-1,5-dimethyl-2-phenyl-1H-pyrazol-3(2H)-one, 98.0%, 25g